Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Update Venetoclax in CLL
Leukemia & Lymphoma Society
NCCN Guidelines for Patients for CLL
Cancer.gov
ASH: COVID-19 Resources for Managing Blood Cancers